Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

Successive clinical application of vitamin D and bumetanide in children with autism spectrum disorder

(2020) Jun-Yan Feng et al.   MEDICINE

Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios

(2020) Lingli Zhang et al.   Translational Psychiatry

Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders

(2020) Melissa S. Zhou et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study

(2020) Dorinde M. van Andel et al.   Molecular Autism

Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase Two, Superiority Trial

(2020) Jan J. Sprengers et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Bumetanide for autism: Open‐label trial in six children

(2020) Elisabeth Fernell et al.   ACTA PAEDIATRICA

Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions

(2018) Joran T. Schulte et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Bumetanide for autism: more eye contact, less amygdala activation

(2018) Nouchine Hadjikhani et al.   Scientific Reports

Glutamate and GABA in autism spectrum disorder—a translational magnetic resonance spectroscopy study in man and rodent models

(2018) Jamie Horder et al.   Translational Psychiatry

Autism spectrum disorder

(2018) Catherine Lord et al.   LANCET

Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials

(2018) B. Jordan James et al.   ANNALS OF PHARMACOTHERAPY

Neurodevelopmental Hypothesis about the Etiology of Autism Spectrum Disorders

(2017) Toshio Inui et al.   Frontiers in Human Neuroscience

NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders

(2017) Yehezkel Ben-Ari   TRENDS IN NEUROSCIENCES

Testing the excitation/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes

(2017) Joana Gonçalves et al.   Molecular Autism

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders

(2017) E Lemonnier et al.   Translational Psychiatry

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures

(2016) Yehezkel Ben-Ari et al.   Frontiers in Cellular Neuroscience

A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism

(2015) Lin Du et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders?

(2015) H. Bruining et al.   PEDIATRICS

GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders

(2014) Giada Cellot et al.   Frontiers in Pediatrics

A randomised controlled trial of bumetanide in the treatment of autism in children

(2012) E Lemonnier et al.   Translational Psychiatry

Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital

(2011) Romain Nardou et al.   BRAIN

The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects

(2010) Eric Lemonnier et al.   ACTA PAEDIATRICA

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS